Market Place
Sourcing Support
Day One Announces Dr. Samuel Blackman’s Retirement
20 Nov 2024 //
GLOBENEWSWIRE
Day One to Participate in Piper Sandler Healthcare Conference
18 Nov 2024 //
GLOBENEWSWIRE
Day One to Report Q3 2024 Financial Results Wednesday, Oct 30, 2024
16 Oct 2024 //
GLOBENEWSWIRE
Day One Announces Oversubscribed $175.0 Million Private Placement
30 Jul 2024 //
GLOBENEWSWIRE
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
30 Jul 2024 //
GLOBENEWSWIRE
Ipsen And Day One Partner On Tovorafenib For Childhood Brain Tumor
25 Jul 2024 //
GLOBENEWSWIRE
Ipsen Secures Ex-US Rights To Day One`s Pediatric Cancer Med For $111M
25 Jul 2024 //
FIERCE PHARMA
Day One inks $1.2B biobucks pact for MabCare’s solid tumor ADC
19 Jun 2024 //
FIERCE PHARMA
XOMA Receives $8.1M Milestone From Day One`s Voucher Sale
12 Jun 2024 //
GLOBENEWSWIRE
Day One Announces Sale of Priority Review Voucher for $108 Million
30 May 2024 //
GLOBENEWSWIRE
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
06 May 2024 //
GLOBENEWSWIRE
Pedia Brain Tumor Fdn Celebrates OJEMDA™ Approval for Pedia Brain Tumor
29 Apr 2024 //
GLOBENEWSWIRE
Day One drug for common childhood brain tumor approved by FDA
24 Apr 2024 //
FDA
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval
23 Apr 2024 //
PRESS RELAESE
Day One`s Tovorafenib Gets FDA Approval For Pediatric pLGG
23 Apr 2024 //
GLOBENEWSWIRE
Day One Reports Fourth Quarter and Full Year 2023 Financial Results
26 Feb 2024 //
GLOBENEWSWIRE
Day One Announces Two New Appointments to Board of Directors
17 Jan 2024 //
GLOBENEWSWIRE
Day One to Present at the 42nd Annual J.P. Morgan Healthcare Conference
19 Dec 2023 //
GLOBENEWSWIRE
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
17 Nov 2023 //
GLOBENEWSWIRE
Day One to Participate in the Piper Sandler 35th Annual Healthcare Conference
14 Nov 2023 //
GLOBENEWSWIRE
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
06 Nov 2023 //
GLOBENEWSWIRE
Day One Announces FDA Acceptance of NDA for Tovorafenib in pLGG
30 Oct 2023 //
GLOBENEWSWIRE
Day One Announces Updated FIREFLY-1 Data for Tovorafenib
11 Sep 2023 //
GLOBENEWSWIRE
Day One jets off with Sprint`s VRK1 program for up to $316M
17 Aug 2023 //
FIERCE BIOTECH
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
07 Aug 2023 //
GLOBENEWSWIRE
Day One Announces Closing of Public Offering
12 Jun 2023 //
GLOBENEWSWIRE
Day One goes to the market for $150M as biotech kicks off NDA request
07 Jun 2023 //
ENDPTS
Day One Announces Proposed Public Offering of Common Stock
06 Jun 2023 //
GLOBENEWSWIRE
Day One Announces Pricing of Public Offering of Common Stock
06 Jun 2023 //
GLOBENEWSWIRE
Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101)
04 Jun 2023 //
GLOBENEWSWIRE
Day One to Participate in the Goldman Sachs 44th Annual Healthcare Conference
30 May 2023 //
GLOBENEWSWIRE
Day One Announces TovorafenibData and Abstracts to be Presented at ASCO
25 May 2023 //
GLOBENEWSWIRE
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
01 May 2023 //
GLOBENEWSWIRE
Day One Announces Abstracts Accepted for Presentation at the 2023 ASCO
26 Apr 2023 //
GLOBENEWSWIRE
Day One Announces Upcoming Presentation at 19th EADO Congress
12 Apr 2023 //
GLOBENEWSWIRE
Day One Reports Fourth Quarter and Full Year 2022 Financial Results
06 Mar 2023 //
GLOBENEWSWIRE
Day One to Participate in the Cowen 43rd Annual Health Care Conference
27 Feb 2023 //
GLOBENEWSWIRE
Day One Announces Data from Phase 2 FIREFLY-1 Trial for Tovorafenib
08 Jan 2023 //
GLOBENEWSWIRE
Day One to Present at the 41st Annual J.P. Morgan Healthcare Conference
20 Dec 2022 //
GLOBENEWSWIRE
Day One Announces Cooperative R&D Agreement with NCI of Tovorafenib
17 Oct 2022 //
GLOBENEWSWIRE
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
04 Aug 2022 //
GLOBENEWSWIRE
Day One to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
02 Aug 2022 //
GLOBENEWSWIRE
Day One Announces Closing of UPO and Full Exercise of the Underwriters` Option
21 Jun 2022 //
GLOBENEWSWIRE
Day One spends day 2 hitting up public markets for $150M
15 Jun 2022 //
FIERCEBIOTECH
Day One Announces Proposed Public Offering of Common Stock
14 Jun 2022 //
GLOBENEWSWIRE
Day One Announces Pricing of Upsized Public Offering of Common Stock
14 Jun 2022 //
GLOBENEWSWIRE
Day One`s share price doubles on brain tumor drug data
13 Jun 2022 //
FIERCEBIOTECH
Day One`s Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib
12 Jun 2022 //
GLOBENEWSWIRE
Day One Begins Dosing in PIb/II Combination Study with Tovorafenib
23 May 2022 //
GLOBENEWSWIRE
Day One Biopharmaceuticals Cut to “Sell” at Zacks Investment Research
18 May 2022 //
DEFENSE WORLD
Day One Reports First Quarter 2022 Financial Results
12 May 2022 //
GLOBENEWSWIRE
Day One to Present at the 21st Annual Needham Virtual Healthcare Conference
06 Apr 2022 //
GLOBENEWSWIRE
Day One Reports Q4 and FY 2021 Financial Results
07 Mar 2022 //
GLOBENEWSWIRE
Day One Reports Second Quarter 2021 Financial Results and Corporate Progress
10 Aug 2021 //
GLOBENEWSWIRE
Day One Reports Second Quarter 2021 Financial Results and Corporate Progress
10 Aug 2021 //
GLOBENEWSWIRE
Day One Receives Orphan Designation from the European Commission for DAY101
21 Jun 2021 //
GLOBENEWSWIRE
Day One Announces First Patient Dosed in FIREFLY-1 Pivotal Phase 2
11 May 2021 //
BUSINESSWIRE
